196 related articles for article (PubMed ID: 21609375)
1. Hepatic steatosis is not always a contraindication for cadaveric liver transplantation.
Deroose JP; Kazemier G; Zondervan P; Ijzermans JN; Metselaar HJ; Alwayn IP
HPB (Oxford); 2011 Jun; 13(6):417-25. PubMed ID: 21609375
[TBL] [Abstract][Full Text] [Related]
2. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.
Lee DD; Croome KP; Shalev JA; Musto KR; Sharma M; Keaveny AP; Taner CB
Ann Hepatol; 2016; 15(1):53-60. PubMed ID: 26626641
[TBL] [Abstract][Full Text] [Related]
3. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ
Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740
[TBL] [Abstract][Full Text] [Related]
4. Effect of steatosis donor liver transplantation on hepatocellular carcinoma recurrence: experience at a single institution.
Teng da H; Zhu ZJ; Zheng H; Deng YL; Sun LY; Pan C; Liu YH; Song HL; Shen ZY
Hepatogastroenterology; 2012 May; 59(115):858-62. PubMed ID: 22389257
[TBL] [Abstract][Full Text] [Related]
5. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study.
Gabrielli M; Moisan F; Vidal M; Duarte I; Jiménez M; Izquierdo G; Domínguez P; Méndez J; Soza A; Benitez C; Pérez R; Arrese M; Guerra J; Jarufe N; Martínez J
Ann Hepatol; 2012; 11(6):891-8. PubMed ID: 23109453
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts.
Croome KP; Wall W; Quan D; Vangala S; McAlister V; Marotta P; Hernandez-Alejandro R
Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):372-6. PubMed ID: 22893463
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
[TBL] [Abstract][Full Text] [Related]
8. Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding.
Bispo M; Marcelino P; Marques HP; Martins A; Perdigoto R; Aguiar MJ; Mourão L; Barroso E
Liver Transpl; 2011 Mar; 17(3):270-8. PubMed ID: 21384509
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of liver transplantations using donations after circulatory death: a single-center experience.
Meurisse N; Vanden Bussche S; Jochmans I; Francois J; Desschans B; Laleman W; Van der Merwe S; Van Steenbergen W; Cassiman D; Verslype C; Aerts R; Nevens F; Pirenne J; Monbaliu D
Transplant Proc; 2012 Nov; 44(9):2868-73. PubMed ID: 23146544
[TBL] [Abstract][Full Text] [Related]
10. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors.
Wong TC; Fung JY; Chok KS; Cheung TT; Chan AC; Sharr WW; Dai WC; Chan SC; Lo CM
Liver Transpl; 2016 Feb; 22(2):226-36. PubMed ID: 26359934
[TBL] [Abstract][Full Text] [Related]
11. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.
Spitzer AL; Lao OB; Dick AA; Bakthavatsalam R; Halldorson JB; Yeh MM; Upton MP; Reyes JD; Perkins JD
Liver Transpl; 2010 Jul; 16(7):874-84. PubMed ID: 20583086
[TBL] [Abstract][Full Text] [Related]
12. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation.
Fiorentino M; Vasuri F; Ravaioli M; Ridolfi L; Grigioni WF; Pinna AD; D'Errico-Grigioni A
Liver Transpl; 2009 Dec; 15(12):1821-5. PubMed ID: 19938115
[TBL] [Abstract][Full Text] [Related]
14. Single-Center Experience Using Marginal Liver Grafts in Korea.
Park PJ; Yu YD; Yoon YI; Kim SR; Kim DS
Transplant Proc; 2018 May; 50(4):1147-1152. PubMed ID: 29731083
[TBL] [Abstract][Full Text] [Related]
15. A score model for the continuous grading of early allograft dysfunction severity.
Pareja E; Cortes M; Hervás D; Mir J; Valdivieso A; Castell JV; Lahoz A
Liver Transpl; 2015 Jan; 21(1):38-46. PubMed ID: 25204890
[TBL] [Abstract][Full Text] [Related]
16. Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival.
Lee DD; Singh A; Burns JM; Perry DK; Nguyen JH; Taner CB
Liver Transpl; 2014 Dec; 20(12):1447-53. PubMed ID: 25179581
[TBL] [Abstract][Full Text] [Related]
17. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
Croome KP; Lee DD; Croome S; Nakhleh RE; Abader Sedki Senada P; Livingston D; Yataco M; Taner CB
Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923
[TBL] [Abstract][Full Text] [Related]
18. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
Botha JF; Thompson E; Gilroy R; Grant WJ; Mukherjee S; Lyden ER; Fox IJ; Sudan DL; Shaw BW; Langnas AN
Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
[TBL] [Abstract][Full Text] [Related]
19. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
[TBL] [Abstract][Full Text] [Related]
20. Similar liver transplantation survival with selected cardiac death donors and brain death donors.
Dubbeld J; Hoekstra H; Farid W; Ringers J; Porte RJ; Metselaar HJ; Baranski AG; Kazemier G; van den Berg AP; van Hoek B
Br J Surg; 2010 May; 97(5):744-53. PubMed ID: 20393979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
